Table 4 Predicted vs. actual costs in the validation/test population, by MS or general health score disease status tertilesa
Disease status tertile | |||
|---|---|---|---|
Low | Medium | High | |
MS score | |||
n | 3902 | 3801 | 3682 |
Predicted costs, $ | |||
Mean (SD) | 5047 (2867) | 8583 (5397) | 20,743 (34,041) |
Median (IQR) | 4269 (3393–5712) | 7193 (5359–10,042) | 12,941 (8926–21,055) |
Minimum | 2149 | 2415 | 3642 |
Maximum | 55,398 | 82,177 | 1,046,113 |
Actual costs, $ | |||
Mean (SD) | 5143 (9204) | 8923 (12,770) | 18,176 (27,936) |
Median (IQR) | 2688 (1065–6052) | 5344 (2617–10,210) | 10,215 (5212–19,976) |
Minimum | 0 | 0 | 0 |
Maximum | 241,470 | 293,690 | 499,099 |
General health, score | |||
n | 4400 | 3426 | 3559 |
Predicted costs, $ | |||
Mean (SD) | 5243 (2630) | 8202 (4413) | 21,781 (34,500) |
Median (IQR) | 4507 (3471–6260) | 7175 (5239–10,019) | 13,973 (9567–22,598) |
Minimum | 2149 | 2638 | 3552 |
Maximum | 39,259 | 73,002 | 1,046,113 |
Actual costs, $ | |||
Mean (SD) | 5233 (7947) | 8455 (10,609) | 19,363 (29,432) |
Median (IQR) | 2950 (1187–6195) | 5510 (2686–10,350) | 10,725 (5429–21,577) |
Minimum | 0 | 0 | 0 |
Maximum | 133,669 | 135,713 | 499,099 |